Monday, September 19, 2016

Bayer ups sales targets for top-selling drugs after Monsanto deal

FRANKFURT, Sept 20 (Reuters) - German drugmaker Bayer

said its two best-selling drugs had a higher annual

peak sales potential than previously targeted, after the agreed

$66 billion takeover of...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)